Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Fate Therapeutics, Inc. (FATE)

« Back to company index

FATE Chatter Timeline

Stock Ticker for FATE

Most Active Tweeters for FATE

UserTweets
@JRMKE3 12
@Scorpionblue13 7
@Tickeron 5
@Estimize 4
@MarcJacksonLA 4

Recent Tweets for FATE

SeekingAlpha @SeekingAlpha
$FATE - Fate Therapeutics, Inc. (FATE) CEO Scott Wolchko on Q2 2021 Results - Earnings Call Transcript.… https://t.co/reKT1TIM61
3:08am
JRMKE3 @JRMKE3
$FATE Scott’s last answer in the Q/A reinforces my belief that the company will “go the distance” @larrywabrams.
12:08am
JRMKE3 @JRMKE3
$FATE @GuggenheimPtnrs Way to try and sneak that question past SW on 596 prior to the data release.
12:08am
JRMKE3 @JRMKE3
$FATE FT596 cleared amended protocol with the FDA from single administration to two doses.
12:08am
JRMKE3 @JRMKE3
$FATE Durability update on the first 11 patients (8/19 event) in FT516 B-Cell Lymphomas.
12:08am
Briefingcom @Briefingcom
$FATE: Fate Therapeutics misses by $0.06, beats on revs https://t.co/SjI90w8wqm
August 4th 2021, 10:08pm
mehabecapital @mehabecapital
(Earnings) Fate Therapeutics ( $FATE ) Actual.EPS=-0.58 vs Est.EPS=-0.5197, Actual.Rev=13.41M vs Est.Rev=6.75M, Las… https://t.co/VwHameEtC6
August 4th 2021, 8:08pm
mediasentiment @mediasentiment
$FATE new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 1049
August 4th 2021, 8:08pm
EdgarInsider @EdgarInsider
A new filing Form 10-Q [Quarterly Report] has been made at the SEC by $FATE FATE THERAPEUTICS INC https://t.co/JtCdMObzM1
August 4th 2021, 8:08pm
MarcJacksonLA @MarcJacksonLA
$FATE Fate Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Operational Progress https://t.co/1XawSRYdSm
August 4th 2021, 8:08pm
Estimize @Estimize
Great work by Cantor_22 who takes the win for $FATE beating 6 other analysts and the Wall Street Consensus - https://t.co/YOji7rj75x
August 4th 2021, 8:08pm
Estimize @Estimize
$FATE misses the Estimize EPS Consensus by 6c and beats the Estimize Revenue Consensus by $5.02M. Reports FQ2 earni… https://t.co/POgnER8GCo
August 4th 2021, 8:08pm
Estimize @Estimize
$FATE reports FQ2 earnings of -58c EPS and $13.41M Revs - https://t.co/w8CN8mVxh2
August 4th 2021, 8:08pm
investor_feed @investor_feed
$FATE 10-Q Fate Therapeutics (4 Aug, 4:13pm) ? 2021 Q2 Earnings https://t.co/mlyzBLvZKp #FATE #10Q #FateTherapeutics #Earnings
August 4th 2021, 8:08pm
SwingJoy1 @SwingJoy1
$FATE No movement here AH?
August 4th 2021, 8:08pm
EdgarInsider @EdgarInsider
New Form 8-K [Press/News Current Report] entry filed by $FATE FATE THERAPEUTICS INC https://t.co/mXq7Gdp29S
August 4th 2021, 8:08pm
investor_feed @investor_feed
$FATE 8-K Fate Therapeutics (4 Aug, 4:05pm) ? Fate Therapeutics Reports Second Quarter 2021 Financial Results… https://t.co/FGsLlASZDZ
August 4th 2021, 8:08pm
ethanFlare @ethanFlare
$FATE - Fate Therapeutics EPS misses by $0.05, beats on revenue Cap size: mid, Float 85.0%, Short Interest 14.6%, I… https://t.co/DXDkpkvvPP
August 4th 2021, 8:08pm
MarketCurrents @MarketCurrents
$FATE - Fate Therapeutics EPS misses by $0.05, beats on revenue https://t.co/XH43zJTWBy
August 4th 2021, 8:08pm
FlashAlert_me @FlashAlert_me
$FATE [15s. delayed]: Issued Press Release on August 04, 16:01:00: Fate Therapeutics Reports Second Quarter 2021 Fi… https://t.co/jmOUelr1G9
August 4th 2021, 8:08pm
StockNewsBot2 @StockNewsBot2
$FATE Fate Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Operational Progress https://t.co/2fioH987Xb
August 4th 2021, 8:08pm
stock_titan @stock_titan
$FATE Fate Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Operational Progress https://t.co/jtW1oWV1H2
August 4th 2021, 8:08pm
Scorpionblue13 @Scorpionblue13
question..can $fate or other immunotherapy be powerful enough to replace surgery in early or later cancer stages? i… https://t.co/xmDm3Ov8Nl
August 4th 2021, 7:08pm
KlendathuCap @KlendathuCap
$MRNA should buy $FATE just for the lols
August 4th 2021, 7:08pm
StockPods @StockPods
$FATE Earnings Call Today: 5:00 PM EST Webcast: https://t.co/NvCxJwzNef Signup for the StockPods BETA now: https://t.co/Vma4E2hQ99
August 4th 2021, 7:08pm
MarcJacksonLA @MarcJacksonLA
$FATE Traders Purchase High Volume of Put Options on Fate Therapeutics | https://t.co/NKb5pRLCDo https://t.co/BVORYOi5IA
August 4th 2021, 4:08pm
Estimize @Estimize
$FATE reports after the close, Estimize Consensus -0 EPS and +1.34M Revs compared to WS - https://t.co/JC4oeBskOY
August 4th 2021, 3:08pm
JRMKE3 @JRMKE3
$FATE ARK is ~40K shares short of 9M in “K” and “G”. An unreal level of accumulation that began in early January wi… https://t.co/7C1Dle5Vag
August 4th 2021, 2:08pm
OptionHunt @OptionHunt
Ticker $FATE Unusual Volume Detected: 27.80% over average
August 4th 2021, 2:08pm
MarcJacksonLA @MarcJacksonLA
$FATE Fate Therapeutics Appoints Yuan Xu to its Board of Directors https://t.co/iRxC5ckXKB via @Bakersfieldcali
August 4th 2021, 1:08pm
BotLedge @BotLedge
$FATE - Dr. Xu is not a party to any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K… https://t.co/UVoi05yUQc
August 4th 2021, 1:08pm
EdgarInsider @EdgarInsider
SEC Form 8-K [Press/News Current Report] filed by $FATE FATE THERAPEUTICS INC https://t.co/j6goPKsQRq
August 4th 2021, 1:08pm
investor_feed @investor_feed
$FATE 8-K Fate Therapeutics (4 Aug, 9:20am) ? Fate Therapeutics Appoints Yuan Xu to its Board of Directors… https://t.co/5QY90RfklQ
August 4th 2021, 1:08pm
fintel_io @fintel_io
Also, if you are new to $FATE here's a background article on Finpedia for you https://t.co/dbgrsQOKWx
August 4th 2021, 1:08pm
sbwcws @sbwcws
Fate Therapeutics appoints Yuan Xu to board of directors Legend Biotech $FATE $LEGN
August 4th 2021, 12:08pm
StockNewsBot2 @StockNewsBot2
$FATE Fate Therapeutics Appoints Yuan Xu to its Board of Directors https://t.co/CDZbLbVH7v
August 4th 2021, 12:08pm
stock_titan @stock_titan
$FATE Fate Therapeutics Appoints Yuan Xu to its Board of Directors https://t.co/SUB2ys0ojX
August 4th 2021, 12:08pm
PersimmonTI @PersimmonTI
$FATE And quietly, quietly... we have our first iPSC-derived CAR-T cell therapy:… https://t.co/Nl037fTVgq
August 3rd 2021, 10:08pm
MarketCurrents @MarketCurrents
$FATE - Fate Therapeutics Q2 2021 Earnings Preview https://t.co/NmRAor0gFn
August 3rd 2021, 9:08pm
Tickeron @Tickeron
Fate Therapeutics Inc to report earnings on August 04, 2021. Earnings per share (EPS) estimate: $-0.52 $FATE… https://t.co/FfVJ0LrQoT
August 3rd 2021, 7:08pm
JRMKE3 @JRMKE3
$FATE Let’s hope FT576 doesn’t take a 13-month turnaround from IND clearance to initial dosing. 8/24/21 will be six… https://t.co/uJkJFl2J7R
August 3rd 2021, 6:08pm
Scorpionblue13 @Scorpionblue13
$gild $fate frankly I think a cure for cancer should be free. how is that gonna work out for investors? or if gover… https://t.co/4PIYrHdeSC
August 3rd 2021, 5:08pm
YMuer @YMuer
$FATE https://t.co/RmySkMrJHQ
August 3rd 2021, 11:08am
retailbiotech @retailbiotech
@BiotechAnalysst $fate is next here it coming #nk cells
August 3rd 2021, 5:08am
dhovekamp42 @dhovekamp42
@maddstone1 CAR NK are theorethical nice especially when build from iPSC-derived cell-lines like $FATE does but eve… https://t.co/f2F4hKRjRN
August 3rd 2021, 3:08am
John_galt1111 @John_galt1111
$FATE announced today that the first patient has been treated with FT819, an off-the-shelf chimeric antigen recepto… https://t.co/hsXVQi5wcO
August 2nd 2021, 11:08pm
Briefingcom @Briefingcom
$FATE: Fate Therapeutics announces treatment of first patient in Phase 1 trial of FT819 https://t.co/7QdDH97bpb
August 2nd 2021, 11:08pm
VSquared9 @VSquared9
$FATE announced that the first patient has been treated with FT819, an off-the-shelf chimeric antigen receptor (CAR… https://t.co/7uXCWkemSt
August 2nd 2021, 10:08pm
newsfilterio @newsfilterio
Fate Therapeutics treats first patient in early-stage FT819 trial $FATE https://t.co/vrFbNamiJY
August 2nd 2021, 10:08pm
Biotech2k1 @Biotech2k1
@StocksnScotch Maybe use $FATE's mega bubble value to buy something?
August 2nd 2021, 10:08pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2021. All rights reserved.